annmarie: let's get to sam fazeli from bloomberg intelligence. ming out with a milestone on mask wearing. does science support this? sam: good morning. yes. the evidence suggests that when everybody is vaccinated, my understanding is that what they have suggested, if you are vaccinated and indoors, you don't need to wear a mask. the amount of virus in your nasal passages, in your mouth, etc., is lower, so the risk of passing a virus from one person to another should be lower, assuming nobody has any of these new super variants that are running around. annmarie: what do we know so far about the vaccine efficacy on the super variants, like the one prime minister boris is worried about from india? sam: not a huge amount. what we have to do is basically in for information from the bits and pieces of data that we have. i have done that in a note that is going out in a couple of hours. it suggests that the [ indiscernible] version of this virus that was like what we used to call the variant first found in india, now this is a variant on that variant. we

tom: sam fazeli, thank you so much. truly expert on these issues.argo emails in and says i mispronounced viagra. lisa: i think is viagra. i am not the target demographic. this is a really important point. it goes to not just vaccines but antibiotics. there is a question of why we have not had more development of the essential medication. why there has been so much focus on things that cater to much smaller subsets of the population but could be more expensive medication. this is the conundrum. our intellectual property system has been under attack for a long time from all sides. how do you arrange it in a more fair way. this debate will continue to rage. tom: the debate will rage but the american pharmaceuticals will stall and delay if they can. our good news is you need to stay with us. tomorrow will be jobs day, without question the most fascinating jobs day i have ever seen. michael mckee would agree with me on that. we will give you complete coverage and go beneath the headline data at 8:30. harvey pitt, i always learn something with mr. pitt. b

we are joined by sam fazeli, bloomberg intelligence senior pharmaceutical analyst. e away from the conversation? sam: obviously they are having this issue with manufacturing. one of the things we've been talking about is with the idea of ip waivers anyone will scramble to try to buy equipment and bags and raw materials. even the company that has the billions of dollars in the bag cannot get access to some of these things. novavax has been around a long time. there is an undercurrent of thinking among investors that they are not as effective as moving some of these things forward. i am hopeful -- this is a vaccine the world needs. we need the extra doses and they would be perfectly suited for use in the more developed world where refrigeration and freezing is tougher. alix: what did you make of the idea they can combat multiple variants with one shot. is this a solution to india? stan: i do not know if it is a solution to india because i'm not convinced what the problem in india is yet. for the future of having three or four different representations of the virus in t

let's bring in sam fazeli.e is a tension between northern european countries that provide tourist, the u.k., germany, the netherlands, and what is happening in the destination countries, which are very keen to welcome. in terms of getting technology in place, is your sense that is going to be enough? is your sense europe is far enough advanced to make a significant push to have a reasonably normal travel experience this summer? sam: that is a very interesting question. it is quite complex to answer that. if we are only talking about traveling within the european union, then i think this could work because there could be a seamless system that folks can use for the digital certificates, whatever shape they actually are. if we are talking about the u.s. people coming over or people coming from the u.k. to europe, that will lead require coordination with the other countries. i'm not sure whether you're just spoke about how correlated -- whether your guest spoke about how coordinated this is. we have u.k. transport

joining us now is sam fazeli, who leads the pharma coverage on bloomberg intelligence.o get to what we are seeing right now. how bad is india currently? are we at the peak, or does it spread elsewhere? sam: hi, alix. if you look at the chart of the data reported, it looks like they are on a trajectory to at least show a slight reduction in the past few days and potentially going forward, but it is impossible to know because the virus has a path of its own. the only way to stop it is to stop people being near each other. . they need to lock down. that is how you get that number down. that is the same for anywhere. guy: and that is being resisted by modi right now. are we going to see and other large countries, people talking about in africa, what we have seen in india? are we going to see it replicated in other developing world countries? sam: it would all depend on the concentration of people in the urban areas because that is what really drives this mostly. if you have that, whichever countries you are thinking about, you are at risk there. that is something i would ce

guy: joining us now is sam fazeli. boris johnson sounds fairly concerned about what is going on.e are seeing a sharp pickup in cases, and the u.k. screens a lot of the tests we do, so you have a pretty good idea of what is going on. why is this indian variance going to be a problem? is it a problem? sam: it is a really interesting situation. this is the first real test of what we are going to do in the future world we are going to have to deal with, where there will be variance or whatever happens, or people slowly losing some immunity with regards to the vaccine effectiveness, that starts showing a spike in cases. this is going to be an interesting dry run for how does a nation deal with the situation. because it is exactly what is likely to happen, whether it is happening now or in three months or whatever. it doesn't matter. you are all vaccinated. a new variant comes and infects people. what do we do? this is going to be very significant, what he says at 5:00. alix: how do we judge italix:? is it about if you are vaccinated and you get it, or are we judging by hospitalization

faze you anymore? nobody wants to see that, let's put more sam rockwell -- >> see more male ass. >> when you get a late-nightink that when people break from it it doesn't. >> i didn't stand up and do a monologue. i didn't wear a tie. everything we did was wrong. >> i'm not sure we're ever going to top this one. guinness book named him the hairiest man in the world. ♪ edelweiss ♪ ♪ edelweiss ♪ ♪ every morning you greet me ♪ >> we let the audience drink. the first night in the middle of the show someone threw up. >> is it asking -- why do they call the town embarrass, minnesota? >> i don't know why they call it. >> all right. >> in the first months of the kimmel show it was a rough road. ♪

faze you anymore? nobody wants to see that. let's put more of sam't know why that format still works, but it does. i think when people break from it, it doesn't. >> i didn't stand up and do a monologue. i didn't wear a tie. everything we did was wrong. i'm not sure we're ever going to top this one. the guinness book named him the hairiest man of the world. ♪ edelweiss, edelweiss, every morning you greet me ♪ >> we let the audience drink the first night in the middle of the show, someone through up. >> ask you, why do they call the town embarrass, minnesota. >> i don't know why they call it. >> all right. in the first months of the kimmel show, it was a rough road. ♪ >> kimmel did not appeal to women. so he had struggles. but like most of these guy, he had to find his voice. >> there were plenty of conversations about what changes should we make to the show to reach a broader demographic. >> when on the rare occasion they look at a bit of video from that first year, it makes every hair on my body stand up. >> all right. we're back with marilyn manson